1,25(OH)2D3 alters growth plate maturation and bone architecture in young rats with normal renal function

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Idelevich, Anna ^a   Kerschnitzki, Michael ^b   Shahar, Ron ^a   Monsonego Ornan, Efrat ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; CALCITRIOL; COLLAGEN TYPE 10; COLLAGEN TYPE 2; FLUOROCHROME; BIOLOGICAL MARKER;

AGGRECAN GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE DEFECT; BONE MATURATION; BONE MINERALIZATION; BONE REMODELING; BONE STRUCTURE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL HYPERPLASIA; CELL MATURATION; CELL PROLIFERATION; COLLAGEN TYPE 10 GENE; COLLAGEN TYPE 2 GENE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORTICAL BONE; GENE; GROWTH PLATE; HISTOLOGY; IN SITU HYBRIDIZATION; IN VITRO STUDY; KIDNEY FUNCTION; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; OSTEOCLAST ACTIVITY; PHENOTYPE; PROTEIN LOCALIZATION; RAT; STRUCTURE ANALYSIS; AGING; ANIMAL; BONE DEVELOPMENT; CELL LINE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HYPERTROPHY; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; PATHOLOGY; PHYSIOLOGY; POROSITY; SPRAGUE DAWLEY RAT; TIBIA;

ANIMALIA; RATTUS;

AGING; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CALCIFICATION, PHYSIOLOGIC; CALCITRIOL; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHONDROCYTES; GROWTH PLATE; HYPERTROPHY; KIDNEY; KIDNEY FUNCTION TESTS; MALE; OSTEOGENESIS; POROSITY; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

EID: 79958746847     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020772     Document Type: Article

References (45)

1. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, et al. (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29: 726-776.
2. Dusso AS, Brown AJ, Slatopolsky E, (2005) Vitamin D. Am J Physiol Renal Physiol 289: F8-28.
3. Donohue MM, Demay MB, (2002) Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. Endocrinology 143: 3691-3694.
4. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, et al. (1999) Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140: 4982-4987.
5. Dardenne O, Prud'homme J, Hacking SA, Glorieux FH, St-Arnaud R, (2003) Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). Bone 32: 332-340.
6. Tanaka H, Seino Y, (2004) Direct action of 1,25-dihydroxyvitamin D on bone: VDRKO bone shows excessive bone formation in normal mineral condition. J Steroid Biochem Mol Biol 89-90: 343-345.
7. Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, et al. (2006) Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116: 3150-3159.
8. Naja RP, Dardenne O, Arabian A, St Arnaud R, (2009) Chondrocyte-specific modulation of Cyp27b1 expression supports a role for local synthesis of 1,25-dihydroxyvitamin D3 in growth plate development. Endocrinology 150: 4024-4032.
9. Sanchez CP, (2008) Mineral metabolism and bone abnormalities in children with chronic renal failure. Rev Endocr Metab Disord 9: 131-137.
10. Wesseling K, Bakkaloglu S, Salusky I, (2008) Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol 23: 195-207.
11. Querfeld U, Mak RH, (2010) Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window. Pediatr Nephrol.
12. Sanchez CP, (2010) Growth-plate cartilage in chronic renal failure. Pediatr Nephrol 25: 643-649.
13. Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, et al. (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53: 205-211.
14. Salusky IB, Kuizon BD, Belin TR, Ramirez JA, Gales B, et al. (1998) Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int 54: 907-914.
15. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, et al. (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46: 1160-1166.
16. London GM, Marchais SJ, Guerin AP, Boutouyrie P, Metivier F, et al. (2008) Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19: 1827-1835.
17. Zittermann A, Koerfer R, (2008) Protective and toxic effects of vitamin D on vascular calcification: clinical implications. Mol Aspects Med 29: 423-432.
18. Sanchez CP, He YZ, (2007) Bone growth during daily or intermittent calcitriol treatment during renal failure with advanced secondary hyperparathyroidism. Kidney Int 72: 582-591.
19. Sanchez CP, He YZ, (2003) Effects of thyroparathyroidectomy, exogenous calcium, and short-term calcitriol therapy on the growth plate in renal failure. J Am Soc Nephrol 14: 148-158.
20. Hopper TA, Wehrli FW, Saha PK, Andre JB, Wright AC, et al. (2007) Quantitative microcomputed tomography assessment of intratrabecular, intertrabecular, and cortical bone architecture in a rat model of severe renal osteodystrophy. J Comput Assist Tomogr 31: 320-328.
21. Finch JL, Tokumoto M, Nakamura H, Yao W, Shahnazari M, et al. (2010) Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. Am J Physiol Renal Physiol 298: F1315-1322.
22. Challa TD, Rais Y, Ornan EM, (2010) Effect of adiponectin on ATDC5 proliferation, differentiation and signaling pathways. Mol Cell Endocrinol 323: 282-291.
23. Simsa S, Genina O, Ornan EM, (2007) Matrix metalloproteinase expression and localization in turkey (Meleagris gallopavo) during the endochondral ossification process. J Anim Sci 85: 1393-1401.
24. Simsa S, Hasdai A, Dan H, Ornan EM, (2007) Differential regulation of MMPs and matrix assembly in chicken and turkey growth-plate chondrocytes. Am J Physiol Regul Integr Comp Physiol 292: R2216-2224.
25. Reich A, Maziel SS, Ashkenazi Z, Ornan EM, (2010) Involvement of matrix metalloproteinases in the growth plate response to physiological mechanical load. J Appl Physiol 108: 172-180.
26. Reagan-Shaw S, Nihal M, Ahmad N, (2008) Dose translation from animal to human studies revisited. FASEB J 22: 659-661.
27. Reich A, Jaffe N, Tong A, Lavelin I, Genina O, et al. (2005) Weight loading young chicks inhibits bone elongation and promotes growth plate ossification and vascularization. J Appl Physiol 98: 2381-2389.
28. Ben-Zvi T, Yayon A, Gertler A, Monsonego-Ornan E, (2006) Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling. J Cell Sci 119: 380-387.
29. Reich A, Sharir A, Zelzer E, Hacker L, Monsonego-Ornan E, et al. (2008) The effect of weight loading and subsequent release from loading on the postnatal skeleton. Bone 43: 766-774.
30. Mizobuchi M, Finch JL, Martin DR, Slatopolsky E, (2007) Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int 72: 709-715.
31. Nilsson O, Marino R, De Luca F, Phillip M, Baron J, (2005) Endocrine regulation of the growth plate. Horm Res 64: 157-165.
32. Karsenty G, Kronenberg HM, Settembre C, (2009) Genetic control of bone formation. Annu Rev Cell Dev Biol 25: 629-648.
33. Sandell LJ, Sugai JV, Trippel SB, (1994) Expression of collagens I, II, X, and XI and aggrecan mRNAs by bovine growth plate chondrocytes in situ. J Orthop Res 12: 1-14.
34. Li YC, Pirro AE, Amling M, Delling G, Baron R, et al. (1997) Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A 94: 9831-9835.
35. Dardenne O, Prudhomme J, Hacking SA, Glorieux FH, St-Arnaud R, (2003) Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses. J Bone Miner Res 18: 637-643.
36. Anderson PH, Atkins GJ, (2008) The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med 29: 397-406.
37. Wronski TJ, Halloran BP, Bikle DD, Globus RK, Morey-Holton ER, (1986) Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization. Endocrinology 119: 2580-2585.
38. Erben RG, Scutt AM, Miao D, Kollenkirchen U, Haberey M, (1997) Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow. Endocrinology 138: 4629-4635.
39. Xue Y, Karaplis AC, Hendy GN, Goltzman D, Miao D, (2006) Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles. Endocrinology 147: 4801-4810.
40. Panda DK, Miao D, Bolivar I, Li J, Huo R, et al. (2004) Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279: 16754-16766.
41. Takasu H, Sugita A, Uchiyama Y, Katagiri N, Okazaki M, et al. (2006) c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs. J Clin Invest 116: 528-535.
42. Schoenau E, Saggese G, Peter F, Baroncelli GI, Shaw NJ, et al. (2004) From bone biology to bone analysis. Horm Res 61: 257-269.
43. Suda T, Ueno Y, Fujii K, Shinki T, (2003) Vitamin D and bone. J Cell Biochem 88: 259-266.
44. Shapiro F, (2008) Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater 15: 53-76.
45. High WB, Capen CC, Black HE, (1981) Histomorphometric evaluation of the effects of intermittent 1,25-dihydroxycholecalciferol administration on cortical bone remodeling in adult dogs. Am J Pathol 104: 41-49.